Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Finally POD for ingenuity.
Yep, he could buy ALL of their shares.
Kelly wouldn't dare convert her notes. They too, could be gobbled up though.
He wouldn't need to do a "hostile buyout", KW, KN and RS would openly annoint him COB.
He wouldn't need to spend 15 minutes a day.
A one minute a week fluff tv commercial, or JUST A TWITTER FLITTER would do it.
THAT FOLKS IS HOW WE GET TO $1.00/SHARE.
THE RECRUITER?
BULLDOG 55
A one minute pitch by Elon Musk would do the job.
He could be Chairman of The Board. Interim, pro tem adjunct.
Peeps would listen.
Nah.
I want to be a super rich.
ELON MUSK
Maybe stop sells were triggered by novices.
Not a willingness on core investors.
Conjecturing and rationalizing,
Only Jarman would convert (Kim rolls over).
His latest loan conversion date, 4/2/22 is for a small amount $12,212.00
That conversion (rate of conversion i don't know) should be absorbed pretty readily without any hiccups since it's such a small amount.
All it would take is somebody who loves and knows the product, owns stock in it AND is impeccably credible.
Enter Bulldog 55.
I bet Elon Musk would give him the time of day.
He lives right here in Vegasville.
Have him, some top doctors and top shareholders and BIEL management hang onto Elon and don't let him breathe, escape etc. Lol
Much higher than where we are at.
Doge Coin has 132.7 billion coins.
Price was 74 cents on May 7th of 2021.
Simple extrapolation:
132.7 billion Doge Coins ÷ 24.7 Biel shares = 5.37×
5.37 × 74 cents = $3.975 price per share of BIEL at its Apex.
$3.975
Of course, it would make Elon Musk a trillion-aire.
Us shareholders just multi millionaires.
Ho hummmmmm
ELON MUSK, IF GOT WIND OF BIEL'S ACTIPATCH WOULD INSTANTLY CAUSE A HUGE EXPOSURE AND SUCCESS, JUST AS BIG AS DOGE COIN.
Anybody want to jive him on the Actipatch.
Send him a bunch.
I bet if Orel Hershiser handed him one it would be a done deal.
I AM WILLING TO BET HE WOULD DO MORE THAN A 3 MINUTE SUPERBOWL COMMERCIAL.
Any opinions?
Wow, I just looked at the numbers.
2012 through 2019 has all net losses over 2 million.
2021 had a net loss of $289 thousand.
THAT'S A ONE TENTH THE USUAL LOSS
AND SALES WERE COMPARABLE TO BIEL'S BEST YEARS
Gotcha. Now support the better alternative.
As bad as sales are (lol), I know deep down inside you will go to the Actipatch as your first line of defense in any kind of trauma situation.
Thanks for your candor and honesty.
I still think the majority of people have never heard or seen the Actipatch.
I cut my finger about 2 weeks ago and immediately put an Actipatch on. The throbbing stopped almost immediately.
I wore it to play at the poker table. Everybody was inquisitive as to what that device was. I said it was to accelerate the healing. They then asked its name, how it actually healed etc. I gave the spiel about
New tissue granulation etc.
BUT THE MAIN THING WAS, NOBODY EVER SEEN OR HEARD OF IT
WELL LET'S SEE HERE.
Aspirin was invented in 1897:
In 1897, Felix Hoffman, a German chemist working for the Bayer company, was able to modify salicylic acid to create acetylsalicylic acid, which was named aspirin.
It didn't become available till 1915, 18 years later.
In 1915 aspirin became available to the public without a prescription, making it arguably the first modern, synthetic, over-the-counter, mass-market medicine and a household name around the world.
That's 18 years, and without the FDA trials and bu·reaucracy that we have nowadays. Meaning easier to get approved then.
Just saw start and end dates on Clinicaltrials.gov.
Start May 1st 2022
End date April 30th 2023
GREAT FIND.
Four week study. Hope there is control ie make sure the Actipatch is used each and every night.
Four weeks so results will be fast.
Wish it were a different arthritis like RA or PSA. There, the immune system is at fault. Actipatch comes alive with inflammation of those types. OA has loss of cartilage but still has inflammation.
Wouldn't it be nice if PEMF could regenerate cartilage. Say in conjunction with microfracture condroplasty (blood stem cells released).
NOT THE TRUE STORY.
2020 TOTAL YEAR SALES: $829,563.00
2021 TOTAL YEAR SALES: $1,609,460.00
2021/2020 = 1.94× or 94% increase YOY.
Oh, a 4th quarter is never when a retailer would start to stock up for the Holiday Season.
I will take YOY results versus a quarter over quarter.
Oh, watch Q1 and Q2 take off and I have to eat it up.
WELL STATED.
Post of the day award.
Wow, Great Perspective.
Hurry and ship your post to Kelly Whelan as an ad lib, postscript to their press release Monday.
You have enlightened Dr Staelin's PR by far.
Especially I like:
$200,000 in new orders. NEW BUSINESS
STADA ON BOARD
Stanford Medical Center Clinical Trial For Thumb Arthritis - top notch university in Cali probably number one.
Total Knee Replacement, Major Surgical Center known for TKA, 180 patient plus 180 control group
UC San Diego Researchers in Pilot Stage of Studies on Refractory Phantom Pain & Total Knee/Hip Replacement Pain
BIEL is in talks with 2 Research Teams for Studies on Wound Care.
A) SERENA GROUP?
B) ???????
But noticeably absent was Meraqi/Variant and our Sree Koneru connection.
Yeah, if they do ALL.
Not just a token few.
Shorting a stock, just do get evil gains, is a terrible thing to do to stiffle a company's growth.
Their lifeblood is gone.
And Market Makers
The Department of Justice is reportedly exploring if they can charge stock market short-sellers with the same law used to take down the mafia.
Neat article on the scumbag short sellers.
Read here:
https://markets.businessinsider.com/news/stocks/stock-market-short-sellers-doj-investigation-mafia-law-rico-racketeering-2022-2
WELL TAKING A LOOK BACK AT THE GLOBAL PRESS RELEASE, JANUARY 3RD 2022,
https://www.globenewswire.com/news-release/2022/01/03/2359901/0/en/BioElectronics-Corporation-Announces-Major-Lenders-Forgoing-Interest-for-a-3rd-Consecutive-Year-New-Research-Projects-Underway.html
Titled:
BIOELECTRONICS CORPORATION ANNOUNCES MAJOR LENDERS FORGOING INTEREST FOR A 3rd CONSECUTIVE YEAR; NEW RESEARCH PROJECTS UNDERWAY
and browsing down to the third project (4th paragraph)
***********************************************
The third project also involves an undertaking to determine the effectiveness of the device for a new intended use, i.e., pain reduction and/or improvement in healing rates of chronic wounds. The Company’s management is currently in discussions with a wound research group to conduct a study on whether the RecoveryRx medical device can provide pain relief to those who suffer with chronic lower limb venous ulcers. A venous leg ulcer is the most common type of leg ulcer, accounting for more than 90% of all cases. Venous leg ulcers can develop after a minor injury, where persistently high pressure in the veins of the legs has damaged the skin. While the name of this group cannot yet be disclosed, their team is recognized internationally for being at the forefront of wound healing research. Their large patient volume affords them the ability to conduct clinical trials quickly and efficiently, with more than 100 clinical trials conducted on growth factors, gene therapy, bioengineered skin products and novel pharmaceuticals. Their research efforts have produced more than 130 abstracts, 100 manuscripts and 900 presentations worldwide.
********************************************
IT FITS PERFECTLY WITH THE SERENA GROUP HERE (A Wound Research center):
https://serenagroupinc.com/about/
********************************************
That group happens to be at WOUND WEEK 2022 and being moderated by THOMAS SERENA M.D.:
Innovative Technologies: What’s in the Pipeline? (Part 1)
9:00 am — 10:00 am ET
Moderated by Thomas Serena, MD
Plus Soon to be involved, in a deep way, Meraqi/Viant.
Just the simple question, how can BIEL be in CVS, Target, entrance into Walgreens, Amazon Editor's Choice AND only be at $.0012.
ANYTHING IN TARGET HAS TO BE TOP NOTCH. Target is a "Dividend King". Only like 15 of them. Dividend Kings know exactly what they are doing for 50 years.
Nope, doesn't make sense. WHY SHIP AN OVERSTOCKED, UNDERATED PRODUCT OUT THE DOOR?
YOU WILL ONLY GET HUGE AMOUNT OF PRODUCT RETURNS.
Similar to its a flop world wide? You can't get world wide without flopping way before.
OXYMORON POST
Good old Kelly is patiently waiting to visit.
Hummmmmmmmmm
Seems she "JUST CAN'T WAIT TO SEE SREE"
If you have a field strength (signal strength) meter try it also.
Means Nada.
How do you know what is theirs and what are orders placed through retail brokers? How much is being shorted by MM's?
You are right. Where's their listing of them having BIEL inventory?
Both Adam Staelin and Rick Staelin went to Duke University.
Getting a little more interesting.
Look at the thumbs up on Sree's post on Viant.
Paul Knopick
Adam Staelin
Yep they don't need to. He "really" didn't leave.
Sree is very cool and level headed; he wouldn't leave in disaccord.
JUST A LITLLE THOUGHT.
Here's the clincher.
Sree N Koneru did state that he would consult with BioElectronics even though he moved on. THAT WOULD BE A HUGE CONFLICT OF INTEREST AND EXPOSE THE PROPRIETARY INTERESTS OF MERAQI. Unless of course he's on board Meraqi, at both BioElectronics's and Meraqi's bequest. A blessed double agent.
If Meraqi wants ALL THE PEMF they can get, but it's still long range away patentable, what a perfect marriage. Couple this with Biel going after top Academic experts, in California, and Viant wanting a solid technology base on the west coast and wallah. PEMF to the nth degree.
The_pro
PS: Sree still owns stock in BIEL. Uh ha!!!
PS II: this post isn't copyrighted like I should have with "Powered by ActiPatch " (don't really care about that one, lol)
Seems like Sree N Koneru left for a legitimately better position.
Seems like Meraqi Medical Devices has a strong bioelectronics program. Here's some goodies:
Neural stimulation devices and systems
TENS stimulator
Therapeutic medical device
Lookie here for the formalities:
https://viantmedical.com/markets/bioelectronics/
JUST SEEING WHAT OUR COMPETITORS COULD POSSIBLY BE DOING.